RecruitingNCT03894917

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Characterizing Disease Biology, Treatment Patterns and Toxicity in Older Adults With Advanced Hepatocellular Carcinoma


Sponsor

The University of Texas Health Science Center at San Antonio

Enrollment

84 participants

Start Date

Sep 13, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting detailed information on older adults newly diagnosed with advanced liver cancer (hepatocellular carcinoma, or HCC). Researchers want to understand how age, overall physical health, existing medical conditions, and treatment choices affect outcomes — since older adults are often underrepresented in clinical trials, yet make up a large share of HCC diagnoses. **You may be eligible if...** - You are 18 or older (with a particular focus on older adults) - You have been newly diagnosed with hepatocellular carcinoma confirmed by biopsy or imaging (CT or MRI) - Your cancer is advanced and cannot be surgically removed, as determined by your treating physician - You have not yet received any prior systemic or localized treatment for HCC **You may NOT be eligible if...** - Your liver cancer can still be surgically removed or treated with localized therapy options - You have already begun systemic or locoregional treatment for your HCC Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERComprehensive Geriatric Assessment (CGA)

Assessments will be done for participants that are 65 years or older.


Locations(1)

Mays Cancer Center

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03894917


Related Trials